Research ArticleCLINICAL INVESTIGATIONS
Imaging of CTLA4 Blockade–Induced Cell Replication with 18F-FLT PET in Patients with Advanced Melanoma Treated with Tremelimumab
Antoni Ribas, Matthias R. Benz, Martin S. Allen-Auerbach, Caius Radu, Bartosz Chmielowski, Elizabeth Seja, John L. Williams, Jesus Gomez-Navarro, Timothy McCarthy and Johannes Czernin
Journal of Nuclear Medicine March 2010, 51 (3) 340-346; DOI: https://doi.org/10.2967/jnumed.109.070946
Antoni Ribas
Matthias R. Benz
Martin S. Allen-Auerbach
Caius Radu
Bartosz Chmielowski
Elizabeth Seja
John L. Williams
Jesus Gomez-Navarro
Timothy McCarthy
In this issue
Journal of Nuclear Medicine
Vol. 51, Issue 3
March 2010
Imaging of CTLA4 Blockade–Induced Cell Replication with 18F-FLT PET in Patients with Advanced Melanoma Treated with Tremelimumab
Antoni Ribas, Matthias R. Benz, Martin S. Allen-Auerbach, Caius Radu, Bartosz Chmielowski, Elizabeth Seja, John L. Williams, Jesus Gomez-Navarro, Timothy McCarthy, Johannes Czernin
Journal of Nuclear Medicine Mar 2010, 51 (3) 340-346; DOI: 10.2967/jnumed.109.070946
Imaging of CTLA4 Blockade–Induced Cell Replication with 18F-FLT PET in Patients with Advanced Melanoma Treated with Tremelimumab
Antoni Ribas, Matthias R. Benz, Martin S. Allen-Auerbach, Caius Radu, Bartosz Chmielowski, Elizabeth Seja, John L. Williams, Jesus Gomez-Navarro, Timothy McCarthy, Johannes Czernin
Journal of Nuclear Medicine Mar 2010, 51 (3) 340-346; DOI: 10.2967/jnumed.109.070946
Jump to section
Related Articles
Cited By...
- Imaging cellular immunotherapies and immune cell biomarkers: from preclinical studies to patients
- MRI techniques for immunotherapy monitoring
- 18F-FLT PET/CT as a Prognostic Imaging Biomarker of Disease-Specific Survival in Patients with Primary Soft-Tissue Sarcoma
- STING-driven interferon signaling triggers metabolic alterations in pancreas cancer cells visualized by [18F]FLT PET imaging
- Predictive value of 3'-deoxy-3'-18F-fluorothymidine PET in the early response to anti-programmed death-1 therapy in patients with advanced non-small cell lung cancer
- Imaging of T-cell Responses in the Context of Cancer Immunotherapy
- Imaging the Cancer Immune Environment and Its Response to Pharmacologic Intervention, Part 2: The Role of Novel PET Agents
- FLT PET/CT imaging of metastatic prostate cancer patients treated with pTVG-HP DNA vaccine and pembrolizumab
- The Immunoimaging Toolbox
- Immune Modulation Therapy and Imaging: Workshop Report
- Prediction of Response to Immune Checkpoint Inhibitor Therapy Using Early-Time-Point 18F-FDG PET/CT Imaging in Patients with Advanced Melanoma
- Immuno-PET of Murine T Cell Reconstitution Postadoptive Stem Cell Transplantation Using Anti-CD4 and Anti-CD8 Cys-Diabodies
- Immune Checkpoint Blockade in Cancer Therapy
- CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire
- Engineered antibody fragments for immuno-PET imaging of endogenous CD8+ T cells in vivo
- PET imaging to non-invasively study immune activation leading to antitumor responses with a 4-1BB agonistic antibody
- PET Imaging of Proliferation with Pyrimidines
- CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans